{"title":"肾癌20年回顾性研究杂志:2003-2022","authors":"S. Pazhanisamy","doi":"10.52733/kcj20n1-20yr","DOIUrl":null,"url":null,"abstract":"These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.","PeriodicalId":74040,"journal":{"name":"Kidney cancer journal : official journal of the Kidney Cancer Association","volume":"629 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A 20-Year Retrospective of Kidney Cancer Journal: 2003-2022\",\"authors\":\"S. Pazhanisamy\",\"doi\":\"10.52733/kcj20n1-20yr\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.\",\"PeriodicalId\":74040,\"journal\":{\"name\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"volume\":\"629 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney cancer journal : official journal of the Kidney Cancer Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52733/kcj20n1-20yr\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney cancer journal : official journal of the Kidney Cancer Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52733/kcj20n1-20yr","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
《肾癌杂志》这20年的历程概括了在肾细胞癌管理方面取得的最引人注目的进展。本文与主编Robert A. Figlin博士进行了问答，回顾了过去二十年的历程，以及战略发展和优化结果的重要里程碑。
A 20-Year Retrospective of Kidney Cancer Journal: 2003-2022
These 20 years of the Kidney Cancer Journal’s journey encapsulate the most dramatic advances ever achieved in the management of RCC. This Q&A with Editor-in-Chief Robert A. Figlin, MD, reflects on the last two decades of the journey, and significant milestones in the evolution of strategies and optimized outcomes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
